Tag: generic drug surveillance
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
How Generic Drugs Saved the U.S. Healthcare System $3.4 Trillion
May, 25 2026
Border and Customs Rules for Bringing Medications Internationally in 2025
Nov, 25 2025
Batch Release Testing: Final Checks Before Pharmaceutical Distribution
Jan, 29 2026
How and Where to Buy Furosemide Online: A Safe Guide for 2026
Jul, 23 2026
Foreign Manufacturing of Generics: FDA Oversight and Standards in 2025
Dec, 17 2025